Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MCUR

Macrocure Ltd. - Ordinary Share (MCUR) Stock Price, News & Analysis

Macrocure Ltd. - Ordinary Share logo

About Macrocure Ltd. - Ordinary Share Stock (NASDAQ:MCUR)

Advanced Chart

Key Stats

Today's Range
$1.51
$1.51
50-Day Range
N/A
52-Week Range
$0.75
$3.20
Volume
N/A
Average Volume
98,746 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Leap Therapeutics Ltd, formerly Macrocure Ltd, is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs for the treatment of chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is a combination of living human white blood cells that have been activated to facilitate the healing process and stimulate wound closure. CureXcell is in Phase III. Its CureXcell addresses each phase of healing in the impaired wound, including the production of growth factors and other biochemical factors involved in fibroblast activation, cell migration and extracellular matrix production, stimulating the body's natural healing process. Its delivery method of direct superficial injection into the chronic wound allows the precise delivery of the cells into the defective wound tissue where they can be effective.

Receive MCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Macrocure Ltd. - Ordinary Share and its competitors with MarketBeat's FREE daily newsletter.

MCUR Stock News Headlines

Jason Co Ltd Ordinary Shares
Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.
Transjamaican Highway Ltd Ordinary Shares
Apollo Micro Systems Ltd Ordinary Shares APOLLO
BeiGene Ltd Ordinary Shares
Fangdd Network Group Ltd - Ordinary Shares - Class A
See More Headlines

MCUR Stock Analysis - Frequently Asked Questions

Macrocure Ltd. - Ordinary Share (NASDAQ:MCUR) issued its quarterly earnings results on Tuesday, November, 17th. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.04.

Based on aggregate information from My MarketBeat watchlists, some other companies that Macrocure Ltd. - Ordinary Share investors own include LinnCo (LNCOQ), California Resources (CRC), (GBSN) (GBSN), (BBEPQ) (BBEPQ), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), (UPLMQ) (UPLMQ) and U.S. Energy (USEG).

Company Calendar

Last Earnings
11/17/2015
Today
1/22/2025

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:MCUR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:MCUR) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners